Bifogade filer
Kurs
+1,53%
Likviditet
5,93 MSEK
Kalender
Est. tid* | ||
2025-10-22 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-18 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-08 | - | X-dag ordinarie utdelning BIOG B 1.95 SEK |
2025-05-08 | - | X-dag bonusutdelning BIOG B 4.95 |
2025-05-07 | - | Årsstämma |
2025-05-07 | - | Kvartalsrapport 2025-Q1 |
2025-02-12 | - | Bokslutskommuniké 2024 |
2024-10-22 | - | Kvartalsrapport 2024-Q3 |
2024-07-23 | - | Kvartalsrapport 2024-Q2 |
2024-05-08 | - | X-dag bonusutdelning BIOG B 5 |
2024-05-08 | - | X-dag ordinarie utdelning BIOG B 1.90 SEK |
2024-05-07 | - | Årsstämma |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-02-07 | - | Bokslutskommuniké 2023 |
2023-10-20 | - | Kvartalsrapport 2023-Q3 |
2023-07-21 | - | Kvartalsrapport 2023-Q2 |
2023-05-08 | - | X-dag bonusutdelning BIOG B 1.45 |
2023-05-08 | - | X-dag ordinarie utdelning BIOG B 1.45 SEK |
2023-05-05 | - | Årsstämma |
2023-05-05 | - | Kvartalsrapport 2023-Q1 |
2023-02-03 | - | Bokslutskommuniké 2022 |
2022-10-21 | - | Kvartalsrapport 2022-Q3 |
2022-07-22 | - | Kvartalsrapport 2022-Q2 |
2022-05-18 | - | Split BIOG B 1:5 |
2022-05-09 | - | X-dag bonusutdelning BIOG B 11.29 |
2022-05-09 | - | X-dag ordinarie utdelning BIOG B 3.63 SEK |
2022-05-06 | - | Årsstämma |
2022-05-06 | - | Kvartalsrapport 2022-Q1 |
2022-02-04 | - | Bokslutskommuniké 2021 |
2021-10-21 | - | Kvartalsrapport 2021-Q3 |
2021-08-12 | - | Kvartalsrapport 2021-Q2 |
2021-05-07 | - | X-dag ordinarie utdelning BIOG B 3.41 SEK |
2021-05-06 | - | Årsstämma |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-02-04 | - | Bokslutskommuniké 2020 |
2020-11-25 | - | Extra Bolagsstämma 2020 |
2020-10-23 | - | Kvartalsrapport 2020-Q3 |
2020-08-13 | - | Kvartalsrapport 2020-Q2 |
2020-05-08 | - | X-dag ordinarie utdelning BIOG B 3.75 SEK |
2020-05-07 | - | Årsstämma |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-02-06 | - | Bokslutskommuniké 2019 |
2019-10-23 | - | Kvartalsrapport 2019-Q3 |
2019-05-09 | - | X-dag bonusutdelning BIOG B 5.95 |
2019-05-09 | - | X-dag ordinarie utdelning BIOG B 4.05 SEK |
2019-02-07 | - | Bokslutskommuniké 2018 |
2018-10-24 | - | Kvartalsrapport 2018-Q3 |
2018-08-17 | - | Kvartalsrapport 2018-Q2 |
2018-04-26 | - | X-dag bonusutdelning BIOG B 4.69 |
2018-04-26 | - | X-dag ordinarie utdelning BIOG B 4.31 SEK |
2018-04-25 | - | Årsstämma |
2018-04-25 | - | Kvartalsrapport 2018-Q1 |
2018-02-08 | - | Bokslutskommuniké 2017 |
2017-10-25 | - | Kvartalsrapport 2017-Q3 |
2017-08-18 | - | Kvartalsrapport 2017-Q2 |
2017-05-04 | - | X-dag bonusutdelning BIOG B 4.34 |
2017-05-04 | - | X-dag ordinarie utdelning BIOG B 3.16 SEK |
2017-05-03 | - | Årsstämma |
2017-05-03 | - | Kvartalsrapport 2017-Q1 |
2017-02-10 | - | Bokslutskommuniké 2016 |
2016-10-25 | - | Kvartalsrapport 2016-Q3 |
2016-08-17 | - | Kvartalsrapport 2016-Q2 |
2016-05-11 | - | X-dag bonusutdelning BIOG B 1.97 |
2016-05-11 | - | X-dag ordinarie utdelning BIOG B 3.03 SEK |
2016-05-10 | - | Årsstämma |
2016-05-10 | - | Kvartalsrapport 2016-Q1 |
2016-03-18 | - | Extra Bolagsstämma 2016 |
2016-02-12 | - | Bokslutskommuniké 2015 |
2015-10-23 | - | Kvartalsrapport 2015-Q3 |
2015-08-18 | - | Kvartalsrapport 2015-Q2 |
2015-05-08 | - | X-dag bonusutdelning BIOG B 1.54 |
2015-05-08 | - | X-dag ordinarie utdelning BIOG B 3.46 SEK |
2015-05-07 | - | Årsstämma |
2015-05-07 | - | Kvartalsrapport 2015-Q1 |
2015-02-12 | - | Bokslutskommuniké 2014 |
2014-10-22 | - | Kvartalsrapport 2014-Q3 |
2014-08-20 | - | Kvartalsrapport 2014-Q2 |
2014-05-07 | - | X-dag bonusutdelning BIOG B 3.65 |
2014-05-07 | - | X-dag ordinarie utdelning BIOG B 3.35 SEK |
2014-05-06 | - | Årsstämma |
2014-05-06 | - | Kvartalsrapport 2014-Q1 |
2014-02-12 | - | Bokslutskommuniké 2013 |
2013-10-23 | - | Kvartalsrapport 2013-Q3 |
2013-08-22 | - | Kvartalsrapport 2013-Q2 |
2013-04-29 | - | X-dag bonusutdelning BIOG B 5.85 |
2013-04-29 | - | X-dag ordinarie utdelning BIOG B 4.15 SEK |
2013-04-26 | - | Analytiker möte 2013 |
2013-04-26 | - | Årsstämma |
2013-04-26 | - | Kvartalsrapport 2013-Q1 |
2013-02-08 | - | Bokslutskommuniké 2012 |
2012-10-23 | - | Analytiker möte 2012 |
2012-10-23 | - | Kvartalsrapport 2012-Q3 |
2012-08-21 | - | Kvartalsrapport 2012-Q2 |
2012-05-09 | - | X-dag ordinarie utdelning BIOG B 1.26 SEK |
2012-05-09 | - | X-dag bonusutdelning BIOG B 2.74 |
2012-05-08 | - | Årsstämma |
2012-05-08 | - | Kvartalsrapport 2012-Q1 |
2012-02-10 | - | Bokslutskommuniké 2011 |
2011-11-17 | - | Kapitalmarknadsdag 2011 |
2011-10-25 | - | Kvartalsrapport 2011-Q3 |
2011-05-11 | - | X-dag bonusutdelning BIOG B 1.08 |
2011-05-11 | - | X-dag ordinarie utdelning BIOG B 0.92 SEK |
2011-05-10 | - | Årsstämma |
2011-05-10 | - | Kvartalsrapport 2011-Q1 |
2011-02-11 | - | Bokslutskommuniké 2010 |
2010-10-27 | - | Kvartalsrapport 2010-Q3 |
2010-08-17 | - | Kvartalsrapport 2010-Q2 |
2010-05-07 | - | X-dag bonusutdelning BIOG B 0.6 |
2010-05-07 | - | X-dag ordinarie utdelning BIOG B 0.90 SEK |
2010-05-06 | - | Kvartalsrapport 2010-Q1 |
2010-02-22 | - | Bokslutskommuniké 2009 |
2009-10-22 | - | Kvartalsrapport 2009-Q3 |
2009-08-18 | - | Kvartalsrapport 2009-Q2 |
2009-04-23 | - | X-dag ordinarie utdelning BIOG B 0.40 SEK |
2009-04-22 | - | Årsstämma |
2009-04-22 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Starting in Q2 2021, BioGaia's products will be sold under the BioGaia brand in Finland, due to the termination of the former distribution agreement with the Finnish company Verman. The takeover of the distribution is a strategic step for BioGaia on the Finnish market. "Finland is an important market for us with one of the world's highest penetrations of probiotic products," says BioGaia's CEO Isabelle Ducellier.
BioGaia is an innovative Swedish healthcare company that has been a world-leader in food supplements with probiotics for more than 30 years and whose products are currently sold in over 100 countries. BioGaia's products contain the patented and well documented probiotic strain L. reuteri Protectis (DSM 17938) that has been tested in more than 150 clinical studies. This unique strain is available only in BioGaia products, which from now on will be sold under the BioGaia brand in Finland.
The new Finnish subsidiary BioGaia Oy will be led by Minna Tähtinen who has extensive experience of probiotics and marketing of pharmaceutical products. Minna has previously worked at Verman, marketing the Rela products and has led the sales and marketing of Gefilus food supplements in Finland.
"I'm very excited about marketing BioGaia's products under our own brand in Finland from now on. With our unique and clinically proven probiotic supplements, I'm confident that BioGaia's position on the Finnish market will remain strong and continue to develop due to active R&D, new indications and line extensions," says Minna Tähtinen, Managing Director of BioGaia Oy in Finland.
BioGaia's products will be available in Finnish pharmacies and pharmacy web shops later this year.
Ulrika Engellau, PR & Corporate Communications Manager
Phone: +46 (0)72 235 15 00
Email: